CHENG HU,JAMES SUTTON,JEFF JIN,KEITH B. PFISTER,LIFENG WAN,MARTIN SENDZIK,PAUL A. BARSANTI,ROBERT KEYES,ROBERT KUCEJKO,XIAODONG LIN,YUE PAN
申请号：
BR112012008074
公开号：
BR112012008074A2
申请日:
2010.07.28
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
The present invention provides a compound of formula (I): and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. Also provided is a method of treating a disease or condition mediated by CDK9.
